These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 9884310

  • 1. Aldose reductase catalyzes the oxidation of naphthalene-1, 2-dihydrodiol for the formation of ortho-naphthoquinone.
    Sugiyama K, Wang TC, Simpson JT, Rodriguez L, Kador PF, Sato S.
    Drug Metab Dispos; 1999 Jan; 27(1):60-7. PubMed ID: 9884310
    [Abstract] [Full Text] [Related]

  • 2. Prevention of naphthalene-1,2-dihydrodiol-induced lens protein modifications by structurally diverse aldose reductase inhibitors.
    Sato S, Sugiyama K, Lee YS, Kador PF.
    Exp Eye Res; 1999 May; 68(5):601-8. PubMed ID: 10328974
    [Abstract] [Full Text] [Related]

  • 3. Aldose reductase the major protein associated with naphthalene dihydrodiol dehydrogenase activity in rat lens.
    Sato S.
    Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3172-8. PubMed ID: 8407226
    [Abstract] [Full Text] [Related]

  • 4. Involvement of aldose reductase in naphthalene cataract.
    Lee AY, Chung SS.
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):193-7. PubMed ID: 9430562
    [Abstract] [Full Text] [Related]

  • 5. Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat.
    Tao RV, Takahashi Y, Kador PF.
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1630-7. PubMed ID: 1901836
    [Abstract] [Full Text] [Related]

  • 6. Aldose reductase as dihydrodiol dehydrogenase. Naphthoquinone formation by rat lens aldose reductase.
    Sato S, Sugiyama K, Carper D.
    Adv Exp Med Biol; 1997 Apr; 414():499-505. PubMed ID: 9059655
    [No Abstract] [Full Text] [Related]

  • 7. Differences in the susceptibility of various aldose reductases to inhibition. II.
    Kador PF, Kinoshita JH, Tung WH, Chylack LT.
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903
    [Abstract] [Full Text] [Related]

  • 8. [Regulation of crystalline lens aldose reductase activity. Nonhyperbolic oxidation kinetics of NADPH by glucose].
    Vartanov SS, Pavlov AR, Iaropolov AI.
    Biokhimiia; 1990 Nov; 55(11):2046-57. PubMed ID: 2128191
    [Abstract] [Full Text] [Related]

  • 9. Ascorbate free radical reductase and ascorbate redox cycle in the human lens.
    Bando M, Obazawa H.
    Jpn J Ophthalmol; 1988 Nov; 32(2):176-86. PubMed ID: 3184551
    [Abstract] [Full Text] [Related]

  • 10. Glyceraldehyde-3-phosphate dehydrogenase as a quinone reductase in the suppression of 1,2-naphthoquinone protein adduct formation.
    Miura T, Shinkai Y, Hirose R, Iwamoto N, Cho AK, Kumagai Y.
    Free Radic Biol Med; 2011 Dec 01; 51(11):2082-9. PubMed ID: 21963991
    [Abstract] [Full Text] [Related]

  • 11. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens.
    Obrosova IG, Stevens MJ.
    Invest Ophthalmol Vis Sci; 1999 Mar 01; 40(3):680-8. PubMed ID: 10067971
    [Abstract] [Full Text] [Related]

  • 12. Regulation of lens aldose reductase activity by nitric oxide.
    Srivastava S, Tammali R, Chandra D, Greer DA, Ramana KV, Bhatnagar A, Srivastava SK.
    Exp Eye Res; 2005 Dec 01; 81(6):664-72. PubMed ID: 15967436
    [Abstract] [Full Text] [Related]

  • 13. Method for isolating tight-binding inhibitors of rat lens aldose reductase.
    Sun G, Ma Y, Gao X, König S, Fales HM, Kador PF.
    Exp Eye Res; 2004 Dec 01; 79(6):919-26. PubMed ID: 15642330
    [Abstract] [Full Text] [Related]

  • 14. Effect of curcumin on galactose-induced cataractogenesis in rats.
    Suryanarayana P, Krishnaswamy K, Reddy GB.
    Mol Vis; 2003 Jun 09; 9():223-30. PubMed ID: 12802258
    [Abstract] [Full Text] [Related]

  • 15. Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (OLETF) rat.
    Kubo E, Maekawa K, Tanimoto T, Fujisawa S, Akagi Y.
    Exp Eye Res; 2001 Sep 09; 73(3):375-81. PubMed ID: 11520112
    [Abstract] [Full Text] [Related]

  • 16. A new approach against sugar cataract through aldose reductase inhibitors.
    Banditelli S, Boldrini E, Vilardo PG, Cecconi I, Cappiello M, Dal Monte M, Marini I, Del Corso A, Mura U.
    Exp Eye Res; 1999 Nov 09; 69(5):533-8. PubMed ID: 10548473
    [Abstract] [Full Text] [Related]

  • 17. Rat lens aldose reductase inhibitory constituents of Nelumbo nucifera stamens.
    Lim SS, Jung YJ, Hyun SK, Lee YS, Choi JS.
    Phytother Res; 2006 Oct 09; 20(10):825-30. PubMed ID: 16881021
    [Abstract] [Full Text] [Related]

  • 18. Lens aldose reductase in diabetic and galactosemic cataracts.
    Parmar NS, Ghosh MN.
    Indian J Physiol Pharmacol; 1981 Oct 09; 25(3):193-200. PubMed ID: 6795119
    [No Abstract] [Full Text] [Related]

  • 19. 2-Chloro-1,4-naphthoquinone derivative of quercetin as an inhibitor of aldose reductase and anti-inflammatory agent.
    Milackova I, Prnova MS, Majekova M, Sotnikova R, Stasko M, Kovacikova L, Banerjee S, Veverka M, Stefek M.
    J Enzyme Inhib Med Chem; 2015 Feb 09; 30(1):107-13. PubMed ID: 24666303
    [Abstract] [Full Text] [Related]

  • 20. The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (ALO1576).
    Xu GT, Zigler JS, Lou MF.
    Exp Eye Res; 1992 Jan 09; 54(1):63-72. PubMed ID: 1541342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.